Pcn29 - Contributing Factors to Lower Effectiveness of Oncology Drugs Compared to Their Efficacy in Clinical Trials

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Factors Contributing to Exacerbating Vulnerabilities in Global Clinical Trials

Frontiers in Pharmacology
Pharmacology
2018English

GetReal: From Efficacy in Clinical Trials to Relative Effectiveness in the Real World

Research Synthesis Methods
Education
2016English

Analysis of Clinical Drug Trials in Children Compared to Clinical Drug Trials in Adults, in Argentina

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2019English

Did Randomized Clinical Trials (RCT) and Continually Are Contributing Evidence for Progress in Radiation Oncology

Journal of Head Neck & Spine Surgery
2018English

Characteristics of Oncology Clinical Trials

JAMA Internal Medicine
Internal Medicine
2013English

Genomics Drugs in Clinical Trials

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2010English

Contributing Factors to Student Success in Anatomy & Physiology: Lower Outside Workload & Better Preparation

American Biology Teacher
AgriculturalEducationBiological Sciences
2004English

Knowledge, Attitudes, and Self-Efficacy as Predictors of Preparedness for Oncology Clinical Trials

Medical Decision Making
Health Policy
2013English

Clinical Trials in Oncology and Defining Benefit

Oncologist
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy